Source: International Journal of Cardiology. Unidade: FM
Subjects: DOENÇAS CARDIOVASCULARES (TERAPIA;PREVENÇÃO E CONTROLE), ADESÃO À MEDICAÇÃO, FÁRMACOS (SISTEMA CARDIOVASCULAR)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BIONDI-ZOCCAI, Giuseppe et al. Aspirin underuse, non-compliance or cessation: Definition, extent, impact and potential solutions in the primary and secondary prevention of cardiovascular disease. International Journal of Cardiology, v. 182, p. 148-154, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.ijcard.2014.12.091. Acesso em: 13 jun. 2024.APA
Biondi-Zoccai, G., Wu, Y., Serrano Jr., C. V., Frati, G., Agostoni, P., & Abbate, A. (2015). Aspirin underuse, non-compliance or cessation: Definition, extent, impact and potential solutions in the primary and secondary prevention of cardiovascular disease. International Journal of Cardiology, 182, 148-154. doi:10.1016/j.ijcard.2014.12.091NLM
Biondi-Zoccai G, Wu Y, Serrano Jr. CV, Frati G, Agostoni P, Abbate A. Aspirin underuse, non-compliance or cessation: Definition, extent, impact and potential solutions in the primary and secondary prevention of cardiovascular disease [Internet]. International Journal of Cardiology. 2015 ; 182 148-154.[citado 2024 jun. 13 ] Available from: https://doi.org/10.1016/j.ijcard.2014.12.091Vancouver
Biondi-Zoccai G, Wu Y, Serrano Jr. CV, Frati G, Agostoni P, Abbate A. Aspirin underuse, non-compliance or cessation: Definition, extent, impact and potential solutions in the primary and secondary prevention of cardiovascular disease [Internet]. International Journal of Cardiology. 2015 ; 182 148-154.[citado 2024 jun. 13 ] Available from: https://doi.org/10.1016/j.ijcard.2014.12.091